Latest News
Stevanato Group expands European adoption of Alina pen injector platform
30 July 2026 - Stevanato Group S.p.A. (NYSE:STVN), a provider of drug containment, drug delivery and diagnostic solutions for the pharmaceutical, biotechnology and life sciences industries, announced on Thursday that liraglutide-based combination pro...
Pfizer reports positive Phase 3 results for LITFULO in nonsegmental vitiligo
30 July 2026 - US biopharmaceutical company Pfizer Inc (NYSE:PFE) on Thursday announced positive topline results from two Phase 3 trials evaluating LITFULO (ritlecitinib) as a potential oral systemic therapy for patients with nonsegmental vitiligo (N...
Octapharma to build USD1.5bn critical care manufacturing facility in Rock Hill, SC
30 July 2026 - Switzerland-based plasma fractionator Octapharma on Wednesday announced plans to establish its first-ever US-based manufacturing and production site at the Palmetto Research Park in Rock Hill, South Carolina.The USD1.5bn project is exp...
Ractigen Therapeutics closes over USD31m financing for project advancement
30 July 2026 - Ractigen Therapeutics, a clinical-stage biotechnology company developing small activating RNA (saRNA) therapeutics and advanced extrahepatic delivery systems, announced on Wednesday the successful closing of a new financing round excee...
10x Genomics and Lausanne University Hospital to collaborate on cancer care research
30 July 2026 - Life science technology company 10x Genomics Inc (Nasdaq:TXG) on Wednesday announced a research collaboration with Lausanne University Hospital (CHUV), a Swiss academic medical centre, to advance research in diagnostic applications of ...